Condition
Spasticity Due to Cerebral Palsy
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed1
Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07034547Not ApplicableRecruiting
Effect of Botulinum Toxin Type A on Motor Function in Children With Cerebral Palsy
NCT06909838Not ApplicableCompletedPrimary
Radial Shockwave for Spasticity in Children With CP or ABI
NCT01405950Phase 1TerminatedPrimary
Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy
Showing all 3 trials